William Joshua Hooghuis, AA | |
1600 Sw Archer Rd, Gainesville, FL 32610-3003 | |
(352) 273-0077 | |
(352) 265-6922 |
Full Name | William Joshua Hooghuis |
---|---|
Gender | Male |
Speciality | Anesthesiology Assistant |
Experience | 14 Years |
Location | 1600 Sw Archer Rd, Gainesville, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861702920 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367H00000X | Anesthesiologist Assistant | AA77 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Uf Health Shands Hospital | Gainesville, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Florida Clinical Practice Association | 0345146254 | 1636 |
News Archive
Astute Medical, Inc., developer of the NephroCheck® Test, today previewed the upcoming AKI & CRRT 2015 conference to be held in San Diego from February 17 to February 20.
Boehringer Ingelheim announced today that the first person has been enrolled in the SENSCIS (Safety and Efficacy ofNintedanib in Systemic SClerosIS) study.
Perrigo Company plc today announced that it has received final approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.
A Swedish population study is helping answer lingering questions about hormone therapy safety. Published online today in Menopause, the journal of The North American Menopause Society, the study shows that estrogen-only therapy carries a lower risk of blood clots than combined estrogen-progestogen therapy, but there is no significantly increased risk of clots with combination therapy when the estrogen is transdermal, and vaginal estrogen doesn't raise the risk at all.
› Verified 9 days ago
Entity Name | Florida Clinical Practice Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063463768 PECOS PAC ID: 0345146254 Enrollment ID: O20031211000099 |
News Archive
Astute Medical, Inc., developer of the NephroCheck® Test, today previewed the upcoming AKI & CRRT 2015 conference to be held in San Diego from February 17 to February 20.
Boehringer Ingelheim announced today that the first person has been enrolled in the SENSCIS (Safety and Efficacy ofNintedanib in Systemic SClerosIS) study.
Perrigo Company plc today announced that it has received final approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.
A Swedish population study is helping answer lingering questions about hormone therapy safety. Published online today in Menopause, the journal of The North American Menopause Society, the study shows that estrogen-only therapy carries a lower risk of blood clots than combined estrogen-progestogen therapy, but there is no significantly increased risk of clots with combination therapy when the estrogen is transdermal, and vaginal estrogen doesn't raise the risk at all.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
William Joshua Hooghuis, AA Po Box 918025, Orlando, FL 32891-8025 Ph: (352) 273-0077 | William Joshua Hooghuis, AA 1600 Sw Archer Rd, Gainesville, FL 32610-3003 Ph: (352) 273-0077 |
News Archive
Astute Medical, Inc., developer of the NephroCheck® Test, today previewed the upcoming AKI & CRRT 2015 conference to be held in San Diego from February 17 to February 20.
Boehringer Ingelheim announced today that the first person has been enrolled in the SENSCIS (Safety and Efficacy ofNintedanib in Systemic SClerosIS) study.
Perrigo Company plc today announced that it has received final approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.
A Swedish population study is helping answer lingering questions about hormone therapy safety. Published online today in Menopause, the journal of The North American Menopause Society, the study shows that estrogen-only therapy carries a lower risk of blood clots than combined estrogen-progestogen therapy, but there is no significantly increased risk of clots with combination therapy when the estrogen is transdermal, and vaginal estrogen doesn't raise the risk at all.
› Verified 9 days ago
David Andrew Hooper, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1600 Sw Archer Rd, Gainesville, FL 32610 Phone: 352-273-6575 Fax: 352-392-7029 | |
Michael John Provost, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1600 Sw Archer Rd, Gainesville, FL 32610 Phone: 352-265-0077 Fax: 352-265-6922 | |
John Howes, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1600 Sw Archer Rd, Box 100254, Gainesville, FL 32610 Phone: 352-273-8610 | |
Morgan Landis, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1515 Sw Archer Rd, Gainesville, FL 32608 Phone: 352-265-0111 | |
Carey D Boudreau Jr., AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1600 Sw Archer Rd, Gainesville, FL 32610 Phone: 352-265-0077 | |
Sunny Patel, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1600 Sw Archer Rd, Gainesville, FL 32610 Phone: 352-273-6438 | |
Christian Andrew Delia, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1600 Sw Archer Rd, Gainesville, FL 32610 Phone: 352-273-8610 |